By Mukundan Sivaraj · AIM Media House
Beckman Coulter Life Sciences announced a strategic partnership with Automata to integrate Beckman’s liquid handling, genomic, and cell analysis instruments with Automata’s LINQ laboratory orchestration platform, the companies said on January 30.
The integration is intended to support faster, more consistent, and more scalable experimentation in research laboratories, according to Beckman. The integration connects Beckman Coulter Life Sciences’ instruments to software-coordinated laboratory workflows rather than operating them as standalone systems.
Under the partnership, Beckman instruments will be linked to a platform that schedules tasks, routes samples, and records execution data across multi-step experimental processes.
The announcement comes amid growing adoption of laboratory automation as research organisations manage higher sample volumes and more complex protocols.
Market research firms estimate the global lab automation market is valued in the multi-billion-dollar range and is expected to grow steadily over the rest of the decade, driven by genomics, cell biology, and drug discovery workloads.
How Lab Automation is Moving Upstream Beckman Coulter Life Sciences supplies liquid handling systems, centrifuges, and analytical instruments used across academic, biotech, and pharmaceutical laboratories. These systems form part of core research infrastructure in genomics, cell analysis, and bioprocessing workflows.
In many laboratories, these instruments operate independently. Multi-step experiments often require researchers to move samples manually between devices, manage timing outside of instrument software, and reconcile data generated by separate systems.
Reviews of preclinical research workflows have linked these handoffs to variability and documentation gaps.
Continue on AIM Media House